Global Transplant Diagnostic Market (HLA Typing - Molecular Assays and Non-Molecular Assays; Product Type - Reagents & Consumables, Instruments & Software & Services) Market Outlook 2024


Report ID : RC-10843 Category : Healthcare Published Date : 31.08.2018
Publisher : Rockville Pages : 65 Format : PDF
Next-Generation Sequencing (NGS) is increasingly being used for HLA typing. Several NSG-based protocols have recently being developed by various companies by building their respective NGS platforms. The report ?Global Transplant Diagnostic Market (HLA Typing - Molecular Assays and Non-Molecular Assays; Product Type - Reagents & Consumables, Instruments & Software & Services) Market Outlook 2024? provides information on the current scenario, market outlook of the global transplant diagnostic. The market is segmented along types of HLA Typing and Product type. Detailed analysis of these segments are provided in the report. The market is further analyzed with detailed market outlook for global as well as regional markets such as North America, Europe and Asia Pacific. Market outlook for overall market as well as for various segments for aforementioned regions has been provided for the period 2018-24. 
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global transplant diagnostic market. The report has been segmented as following:-
Market Segments 
? HLA Typing ? Molecular Assays & Non-Molecular Assays 
? Product Type - Reagents & Consumables, Instruments & Software & Services
Geographical Coverage 
? North America - The US
? Europe - Italy
? Asia Pacific 
Companies Coverage
? Thermo Fisher Scientific Inc.
? F.Hoffman-La Roche Ltd.,
? Abbott Laboratories Inc.
? Qiagen N.V.
? Immucor Inc.
?
1. Executive Summary
2. Research Methodology
3. Transplant Diagnostic
3.1 Overview
3.2 Organ Transplant
3.3 HLA Typing
3.3.1 Overview
3.3.2 Classification
3.3.2.1   Serology
3.3.2.2   Mixed Lymphocyte Culture (MLC)
3.3.2.3   Polymerase Chain Reaction (PCR)
3.3.2.4   Sequencing Based
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Product Type
4.2.2 Market Share by Technology
4.2.3 Market Share by Type of Organ
4.2.4 Market Share by Region
5. Market Segmentation
5.1 HLA Typing
5.1.1 Molecular Assays
5.1.2 Non-Molecular Assays
5.2 Product Type
5.2.1 Reagents & Consumables
5.2.2 Instruments
5.2.3 Software & Services
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Italy
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
7. Market Dynamics
7.1 Industry Trend & Development
7.1.1 Next Generation Sequencing for HLA Typing
7.1.2 Recent Deals
7.1.3 Other Technological Advancements
7.2 Growth Drivers
7.2.1 Rising Demand for Organ Transplants
7.2.2 Increasing Geriatric Population
7.2.3 Prevalence of Chronic Diseases
7.2.4 Government Initiatives
7.3 Challenges
7.3.1 Organ Shortage for Transplant
7.3.2 Limited Medical Reimbursement
7.3.3 Lack of Awareness
7.3.5 Stringent Regulations
8. Competitive Landscape
9. Company Profiles
9.1 Thermo Fisher Scientific Inc.
9.2 F. Hoffman-La Roche Ltd.
9.3 Abbott Laboratories Inc.
9.4 Qiagen N.V.
9.5 Immucor Inc.

Sidebar Menu